about
Fast and high temperature hyperthermia coupled with radiotherapy as a possible new treatment for glioblastoma.High-intensity focused ultrasound plus concomitant radiotherapy: a new weapon in oncology?Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data.Condensed-history Monte-Carlo simulation for charged particles: what can it do for us?Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Comment on "Simulating Radiotherapy Effect in High-Grade Glioma by Using Diffusive Modeling and Brain Atlases"The radiobiology of hypofractionation.Twenty Fraction Prostate Radiotherapy with Intra-prostatic Boost: Results of a Pilot Study.Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio.(Radio)biological optimization of external-beam radiotherapy.An NTCP Analysis of Urethral Complications from Low Doserate Mono- and Bi-Radionuclide Brachytherapy.Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM.Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.4D radiobiological modelling of the interplay effect in conventionally and hypofractionated lung tumour IMRT.Prospects for proton-beam radiotherapy.Conformal radiotherapy at the Royal Marsden Hospital (UK).Perturbation effects in dosimetry: Part I. Kilovoltage x-rays and electrons.Accuracy of pelvic radiotherapy: prospective analysis of 90 patients in a randomised trial of blocked versus standard radiotherapy.Fractionation in normal tissues: the (α/β)eff concept can account for dose heterogeneity and volume effects.Benefits expected from simple conformal radiotherapy in the treatment of pelvic tumours.Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.Converting absorbed dose to medium to absorbed dose to water for Monte Carlo based photon beam dose calculations.Long-term biochemical control of prostate cancer after standard or hyper-fractionation: evidence for different outcomes between low-intermediate and high risk patients.Inconsistency in derivation of C-lambda and CE.Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.Dosimetric response of variable-size cavities in photon-irradiated media and the behaviour of the Spencer-Attix cavity integral with increasing Δ.Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.Incorporation of a combinatorial geometry package and improved scoring capabilities in the EGSnrc Monte Carlo Code system.Modelling the radiotherapy effect in the reaction-diffusion equation.Secondary bremsstrahlung and the energy-conservation aspects of kerma in photon-irradiated media.Characterizing the influence of detector density on dosimeter response in non-equilibrium small photon fields.Cancer therapy combining high-intensity focused ultrasound and megavoltage radiation.Breakdown of Bragg-Gray behaviour for low-density detectors under electronic disequilibrium conditions in small megavoltage photon fields.IMAT-SIM: a new method for the clinical dosimetry of intensity-modulated arc therapy (IMAT).Impact of microscopic disease extension, extra-CTV tumour islets, incidental dose and dose conformity on tumour control probability.The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia.Dosimetric verification of IMAT delivery with a conventional EPID system and a commercial portal dose image prediction tool.
P50
Q30367908-325AC44C-480D-4FAE-99E0-00204FEAA1CAQ30440011-6A545B83-A9E9-40BE-A209-500480287851Q30627479-E9EFE5D5-FD15-4993-9A2B-4726958985B6Q33753812-9D1D022B-694E-4F55-8F5C-A28A75A76423Q34211377-30D1C761-3025-4071-9CE2-F59BEEE99D2AQ36349026-10B17728-98D7-42D6-AFA2-FD3599E8122DQ38386825-60EBCDD8-5CD8-4906-8F59-60A0FD5DE2F0Q38386944-867CF781-461E-4154-A84B-48E9D3D799BCQ38411790-C982A09C-3D45-4182-A217-47DC39A736AEQ38428533-E67518C5-278E-44AE-8536-44F24F22FDDBQ38730585-5AD2761D-CF0C-46A8-AEF5-854EB8EF2207Q38994749-02740B2D-AAFA-4AB8-9DCA-74EC5A8431F1Q39646181-8B50AB42-AC04-4A68-A06B-D1FE8A32040AQ39775116-2B73C7D2-4621-4C3F-849A-878E2CD2B052Q40224314-8704D977-CB56-4D8D-B525-75A472A8923DQ40578113-D844820F-057B-4229-B485-F9E5DEEA6A48Q40620877-73DD7C3E-0964-4D7C-A38A-E2546846086FQ40928542-44FA0307-74B6-4FA1-A14B-78E4D87DB997Q40944410-9388C6B9-FB5B-4496-959D-70F47C6E73C8Q43546217-E54C4F82-0BAB-47AF-869D-12A424AD1CBEQ43903464-D2C0A8B0-473F-4E62-9F9F-CFB014DF0E82Q44657567-6348B597-57FD-4C36-A064-4D843D1C3F28Q44871448-1BD2EA48-D08F-4ADF-B939-D60CB97C41DEQ45081487-1AD6DFC6-DD07-47C9-89C5-C2CC19673A32Q45166352-E3F476F0-25E4-4E85-BE4E-279BCDFC0B56Q45803967-BABFCCB9-93AC-4464-B457-DE63F8935245Q47318526-BDF0F871-AFB7-4944-8BCD-7CC55A403EE8Q47644737-746FFED6-8FA7-4BB3-B70F-1C6778CFD71BQ47770919-5A4928EC-0D44-475B-A105-0192AAFC6212Q48534234-5F31B21E-6909-44A8-A77D-B83136267FA7Q48695134-31C47435-4704-466D-A24B-639C395C5845Q49127221-0551E3FB-75F5-4B6F-BB1E-FB39D1A8B36AQ50242937-3367C3FE-9CDB-4C3C-898F-5E1A3A9B32EAQ50798522-9F442D87-9F44-4EEA-B9A4-0709535695BAQ50918270-E97B6D69-1FD9-45EE-8C32-7E0CC39CC30AQ51336147-B69CD52B-F8AE-47F1-975F-5CFA6B566B76Q51628396-29110FA2-9714-409A-893A-6D3F78828FC9Q51647357-304EE501-33E0-4A84-893D-98F7107D050AQ51694927-B1FC68BA-06DB-4EA0-AC15-EF4E5E1A213BQ51719422-AB1B7AB7-DAC5-4C52-ABEA-2A422C16C306
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alan Nahum
@ast
Alan Nahum
@en
Alan Nahum
@es
Alan Nahum
@nl
Alan Nahum
@sl
type
label
Alan Nahum
@ast
Alan Nahum
@en
Alan Nahum
@es
Alan Nahum
@nl
Alan Nahum
@sl
prefLabel
Alan Nahum
@ast
Alan Nahum
@en
Alan Nahum
@es
Alan Nahum
@nl
Alan Nahum
@sl
P106
P21
P31
P496
0000-0002-6429-9502